StockData
AIM ImmunoTech Inc. logo

AIM ImmunoTech Inc. (AIM) stock

AIMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$0.13−0.01 (-3.75%)

Close on Nov 18, 2026Market cap $3.98MP/E –Yield –

AIM ImmunoTech gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

AIM ImmunoTech's gross profit for the twelve months ending Sep 30, 2015 was -$1.41M. For fiscal 2014 it was -$1.05M. The highest annual figure on record is -$473.00K in fiscal 2009.

Annual gross profit

PeriodPeriod endValueChange
FY2014Dec 31, 2014-$1.05M–
FY2013Dec 31, 2013-$1.08M–
FY2012Dec 31, 2012-$1.78M–
FY2011Dec 31, 2011-$882.00K–
FY2010Dec 31, 2010-$1.21M–
FY2009Dec 31, 2009-$473.00K–

More AIM ImmunoTech figures

See a number that looks wrong?